Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.

Compostos do phenylethyl-phenylethyl-thiourea da novela (PHET) como inibidores do transcriptase reverso e agentes eficazes para o tratamento de tensões resistentes da infecção de HIV, including o mutant, as droga-sensíveis, as drug-resistant, e da multi-droga do HIV.